Schedule 13D ownership disclosure
GLYCOMIMETICS INC
Security class unavailable · CUSIP: 38000Q102
Event date: 2024-02-06
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 7.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001072613-24-000125
- Form type
- SC 13D
- Filer
- CRESCENT BIOPHARMA, INC.
- CIK
- CIK 1253689
- Filed
- Feb 12, 2024
- Reporting period
- Feb 06, 2024
- Description
- Schedule 13D beneficial ownership